The results showed that the levels of TLR4, MyD88, phospho-NF-κB, and NF-κB in the livers were remarkably enhanced in the DSS-induced IBD model group, while those in the PSG-treated groups were significantly reversed (Figures 5(b) and 5(c)). This evidence concerns the gene TLR4 and inflammatory bowel disease.